Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome

Connie Siew Poh Yip; Charlotte Dinkle; Abhishek Mahajan; Muhammad Musib Siddique; Gary John Russell Cook; Vicky Joo-Lin Goh

doi:10.1007/s13244-015-0414-0

Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome

King's College London

Research output: Contribution to journal › Literature review › peer-review

201 Citations (Scopus)

Abstract

In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have been identified as adverse factors in cancer patients. Imaging quantification of body composition such as lean muscle mass and fat distribution is a potentially valuable tool. This review describes the following imaging techniques that may be used to assess body composition: dual-energy X-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). CT and MRI are acquired as part of oncological patient care, thus providing an opportunity to integrate body composition assessment into the standard clinical pathway and allowing supportive care to be commenced as appropriate to improve outcome.

Original language	English
Number of pages	9
Journal	Insights into imaging
DOIs	https://doi.org/10.1007/s13244-015-0414-0
Publication status	E-pub ahead of print - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s13244-015-0414-0

Cite this

@article{fa35c4edb8e44e57afb63d4d77a45b23,

title = "Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome",

abstract = "In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have been identified as adverse factors in cancer patients. Imaging quantification of body composition such as lean muscle mass and fat distribution is a potentially valuable tool. This review describes the following imaging techniques that may be used to assess body composition: dual-energy X-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). CT and MRI are acquired as part of oncological patient care, thus providing an opportunity to integrate body composition assessment into the standard clinical pathway and allowing supportive care to be commenced as appropriate to improve outcome.",

author = "Yip, \{Connie Siew Poh\} and Charlotte Dinkle and Abhishek Mahajan and Siddique, \{Muhammad Musib\} and Cook, \{Gary John Russell\} and Goh, \{Vicky Joo-Lin\}",

year = "2015",

doi = "10.1007/s13244-015-0414-0",

language = "English",

journal = "Insights into imaging",

issn = "1869-4101",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Imaging body composition in cancer patients

T2 - visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome

AU - Yip, Connie Siew Poh

AU - Dinkle, Charlotte

AU - Mahajan, Abhishek

AU - Siddique, Muhammad Musib

AU - Cook, Gary John Russell

AU - Goh, Vicky Joo-Lin

PY - 2015

Y1 - 2015

N2 - In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have been identified as adverse factors in cancer patients. Imaging quantification of body composition such as lean muscle mass and fat distribution is a potentially valuable tool. This review describes the following imaging techniques that may be used to assess body composition: dual-energy X-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). CT and MRI are acquired as part of oncological patient care, thus providing an opportunity to integrate body composition assessment into the standard clinical pathway and allowing supportive care to be commenced as appropriate to improve outcome.

AB - In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have been identified as adverse factors in cancer patients. Imaging quantification of body composition such as lean muscle mass and fat distribution is a potentially valuable tool. This review describes the following imaging techniques that may be used to assess body composition: dual-energy X-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). CT and MRI are acquired as part of oncological patient care, thus providing an opportunity to integrate body composition assessment into the standard clinical pathway and allowing supportive care to be commenced as appropriate to improve outcome.

U2 - 10.1007/s13244-015-0414-0

DO - 10.1007/s13244-015-0414-0

M3 - Literature review

SN - 1869-4101

JO - Insights into imaging

JF - Insights into imaging

ER -

Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this